3 health care stocks off to strong starts in 2024

Key PointsAmgen is up +6% so far and is the Nasdaq-100’s second best performing stock year-to-date.At 20x this year’s projected earnings, Regeneron may still be one of the best values in biotech.Gilead Sciences has gone sideways for the better part of the last five years but ended 2023 on an upswing that may have staying power.5 stocks we like better than AmgenUp 2% five trading days into the new year, global health care stocks have already matched their return for all of 2023. It’s very early, but the sect ...